New scan could reveal hidden cancer spread

NCT ID NCT07457541

Ongoing Diagnosis Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial tests a radioactive imaging agent called Technetium-99m HYNIC-FAPI in 15 people with metastatic lung, pancreas, breast, or colorectal cancer. The goal is to see how well it highlights tumors on SPECT/CT scans. Researchers will measure where the agent goes in the body and how it compares to normal tissue, while also checking for safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Technetium-99m HYNIC-FAPI (a radioactive imaging agent)
What this could lead to: If successful, this could provide a new way to see where cancer has spread, helping doctors plan better treatments.
What could go wrong: This is a very early, small study (15 people) focused on imaging, not treatment. It may not lead to any direct benefit for patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colorectal cancer colorectal neoplasm exocrine pancreatic carcinoma lung cancer lung neoplasm malignant pancreatic neoplasm Neoplasm Metastasis pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) COLORECTAL CANCER (LOCALLY ADVANCED OR METASTATIC) LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) PANCREAS CANCER, METASTATIC

Contacts and locations

Locations

Tomsk National Research Medical Center of the Russian Academy of Sciences

Tomsk, Tomsk Oblast, 634045, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.